Statins in primary prevention of cardiovascular disease

被引：4
作者：
Adham, S. [1 ]
Miranda, S. [2 ]
Doucet, J. [3 ]
Levesque, H. [2 ,4 ]
Benhamou, Y. [2 ,4 ]
机构：
[1] Hop Europeen Georges Pompidou, AP HP, Serv Genet, Ctr Reference Malad Vasc Rares, 20-40 Rue Leblanc, F-75015 Paris, France
[2] CHU Rouen, Dept Med Interne, 1 Rue Germont, F-76031 Rouen, France
[3] CHU Rouen, Hop St Julien, Serv Med Interne Geriatrie & Therapeut, Rue Guillaume Lecointe, F-76140 Le Petit Quevilly, France
[4] UFR Med & Pharm Rouen, Unite Inserm 01096, 22 Blvd Gambetta, F-76000 Rouen, France
来源：
REVUE DE MEDECINE INTERNE | 2018年 / 39卷 / 01期
关键词：
Primary prevention; Cardiovascular disease; Cardiovascular risk; Statins; CHOLESTEROL; CORONARY; RISK; MEN; MANAGEMENT; EVENTS; WOMEN; TRIAL; DYSLIPIDEMIA; PRAVASTATIN;
D O I：
10.1016/j.revmed.2017.08.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Cardiovascular events are the second leading cause of death in France. The assessment of overall cardiovascular risk using a personalized assessment with weighting risk factors can predict the risk of cardiovascular events in ten years. The validated treatments to reduce cardiovascular mortality in primary prevention are few. The use of statins in primary prevention is discussed. We report in this review the updated conclusions from clinical trials regarding the treatment with statins in primary prevention. (C) 2017 Societe Nationale Francaise de Medecine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：42 / 49
页数：8
相关论文
共 41 条
[1]  
Agence francaise de securite sanitaire des produits de sante, RAPP COND RETR MARCH
[2]  
[Anonymous], 2011, WHO I Global atlas on cardiovascular disease prevention and control
[3]  
[Anonymous], 2003, REV PRESCR, V23, P287
[4]  
[Anonymous], 2002, JAMA, V288, P2998
[5]  
Aouba A, 2011, BEH, V22, P249
[6]   2016 ESC/EAS Guidelines for the Management of Dyslipidaemias The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) [J].
Catapano, Alberico L. ;
Graham, Ian ;
De Backer, Guy ;
Wiklund, Olov ;
Chapman, M. John ;
Drexel, Heinz ;
Hoes, Arno W. ;
Jennings, Catriona S. ;
Landmesser, Ulf ;
Pedersen, Terje R. ;
Reiner, Zeljko ;
Riccardi, Gabriele ;
Taskinen, Marja-Riita ;
Tokgozoglu, Lale ;
Verschuren, W. M. Monique ;
Vlachopoulos, Charalambos ;
Wood, David A. ;
Luis Zamorano, Jose .
ATHEROSCLEROSIS, 2016, 253 :281-344
[7]   World Heart Day 2002 - The international burden of cardiovascular disease: Responding to the emerging global epidemic [J].
Bonow, RO ;
Smaha, LA ;
Smith, SC ;
Mensah, GA ;
Lenfant, C .
CIRCULATION, 2002, 106 (13) :1602-1605
[8]  
Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3
[9]   Estimation of ten-year risk of fatal cardiovascular disease in Europe:: the SCORE project [J].
Conroy, RM ;
Pyörälä, K ;
Fitzgerald, AP ;
Sans, S ;
Menotti, A ;
De Backer, G ;
De Bacquer, D ;
Ducimetière, P ;
Jousilahti, P ;
Keil, U ;
Njolstad, I ;
Oganov, RG ;
Thomsen, T ;
Tunstall-Pedoe, H ;
Tverdal, A ;
Wedel, H ;
Whincup, P ;
Wilhelmsen, L ;
Graham, IM .
EUROPEAN HEART JOURNAL, 2003, 24 (11) :987-1003
[10]   Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].
Downs, JR ;
Clearfield, M ;
Weis, S ;
Whitney, E ;
Shapiro, DR ;
Beere, PA ;
Langendorfer, A ;
Stein, EA ;
Kruyer, W ;
Gotto, AM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622
12345